Details

Autor(en) / Beteiligte

• Chaika, Maryanna
• Afat, Saif
• Wessling, Daniel
• Afat, Carmen
• Nickel, Dominik
• Kannengiesser, Stephan
• Herrmann, Judith
• Almansour, Haidara
• Männlin, Simon
• Othman, Ahmed E.
• Gassenmaier, Sebastian

Titel

Deep learning-based super-resolution gradient echo imaging of the pancreas: Improvement of image quality and reduction of acquisition time

Ist Teil von

• Diagnostic and interventional imaging, 2023-02, Vol.104 (2), p.53-59

Ort / Verlag

France: Elsevier Masson SAS

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• •Deep learning-based super-resolution gradient echo imaging results in improved image quality and reduction of acquisition time for MRI of the pancreas.•Deep learning-based super-resolution gradient echo imaging results in less image artifacts via simulated shortening of the acquisition time.•Deep learning-based super-resolution gradient echo imaging can be easily implemented in post-processing workflow without protocol changes. The purpose of this study was to evaluate the impact of a deep learning-based super-resolution technique on T1-weighted gradient-echo acquisitions (volumetric interpolated breath-hold examination; VIBE) on the assessment of pancreatic MRI at 1.5 T compared to standard VIBE imaging (VIBESTD). This retrospective single-center study was conducted between April 2021 and October 2021. Fifty patients with a total of 50 detectable pancreatic lesion entities were included in this study. There were 27 men and 23 women, with a mean age of 69 ± 13 (standard deviation [SD]) years (age range: 33–89 years). VIBESTD (precontrast, dynamic, postcontrast) was retrospectively processed with a deep learning-based super-resolution algorithm including a more aggressive partial Fourier setting leading to a simulated acquisition time reduction (VIBESR). Image analysis was performed by two radiologists regarding lesion detectability, noise levels, sharpness and contrast of pancreatic edges, as well as regarding diagnostic confidence using a 5-point Likert-scale with 5 being the best. VIBESR was rated better than VIBESTD by both readers regarding lesion detectability (5 [IQR: 5, 5] vs. 5 [IQR: 4, 5], for reader 1; 5 [IQR: 5, 5] vs. 4 [IQR: 4, 5]) for reader 2; both P <0.001), noise levels (5 [IQR: 5, 5] vs. 5 [IQR: 4, 5] for reader 1; 5 [IQR: 5, 5] vs. 4 [IQR: 4, 5] for reader 2; both P <0.001), sharpness and contrast of pancreatic edges (5 [IQR: 5, 5] vs. 5 [IQR: 4, 5] for reader 1; 5 [IQR: 5, 5] vs. 4 [IQR: 4, 5] for reader 2; both P <0.001), as well as regarding diagnostic confidence (5 [IQR: 5, 5] vs. 5 [IQR: 4, 5] for reader 1; 5 [IQR: 5, 5] vs. 4 [IQR: 4, 5] for reader 2; both P <0.001). There were no significant differences between lesion sizes as measured by the two readers on VIBESR and VIBESTD images (P > 0.05). The mean acquisition time for VIBESTD (15 ± 1 [SD] s; range: 11–16 s) was longer than that for VIBESR (13 ± 1 [SD] s; range: 11–14 s) (P < 0.001). Our results indicate that the newly developed deep learning-based super-resolution algorithm adapted to partial Fourier acquisitions has a positive influence not only on shortening the examination time but also on improvement of image quality in pancreatic MRI.